Gene · 5607
Papers1,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation. | Mol Oncol | 2025 | 38965815 | PubTator, text mining | PubMed |
| A close-up of regulatory networks and signaling pathways of MKK5 in biotic and abiotic stresses. | Crit Rev Biotechnol | 2025 | 38797669 | PubTator, text mining | PubMed |
| Correction to "The Role of MEK1/2 and MEK5 in Melatonin-Mediated Actions on Osteoblastogenesis, Osteoclastogenesis, Bone Microarchitecture, Biomechanics, and Bone Formation". | J Pineal Res | 2024 | 39722230 | PubTator, text mining | PubMed |
| Sports-Related Genomic Predictors Are Associated with Athlete Status in Chinese Sprint/Power Athletes. | Genes (Basel) | 2024 | 39457375 | PubTator, text mining | PubMed |
| Mechanoresponsive ETS1 causes endothelial dysfunction and arterialization in varicose veins via NOTCH4/DLL4 signaling. | Eur J Cell Biol | 2024 | 38759515 | PubTator, text mining | PubMed |
| Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer. | Front Oncol | 2024 | 38571492 | PubTator, text mining | PubMed |
| A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer. | BioData Min | 2024 | 38378612 | PubTator, text mining | PubMed |
| Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer. | Cancer Rep (Hoboken) | 2024 | 38351531 | PubTator, text mining | PubMed |
| Identification of a Novel Germline PPP4R3A Missense Mutation Asp409Asn on Familial Non-Medullary Thyroid Carcinoma. | Biomedicines | 2024 | 38275415 | PubTator, text mining | PubMed |
| Genetic Association Studies in Restless Legs Syndrome: Risk Variants & Ethnic Differences. | Can J Neurol Sci | 2024 | 38267254 | PubTator, text mining | PubMed |
| Natural products targeting the MAPK-signaling pathway in cancer: overview. | J Cancer Res Clin Oncol | 2024 | 38193944 | PubTator, text mining | PubMed |
| HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells. | Circulation | 2024 | 38099436 | PubTator, text mining | PubMed |
| ClinicalOmicsDB: exploring molecular associations of oncology drug responses in clinical trials. | Nucleic Acids Res | 2024 | 37811874 | PubTator, text mining | PubMed |
| Identification of a chemical probe for lipid kinase phosphatidylinositol-5-phosphate 4-kinase gamma (PI5P4Kγ). | Curr Res Chem Biol | 2023 | 41937984 | PubTator, text mining | PubMed |
| Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer. | Front Oncol | 2023 | 38282676 | PubTator, text mining | PubMed |
| Actionable Driver Events in Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 38203275 | PubTator, text mining | PubMed |
| Genomic analysis identifies risk factors in restless legs syndrome. | medRxiv | 2023 | 38168192 | PubTator, text mining | PubMed |
| Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease. | Cancers (Basel) | 2023 | 38136277 | PubTator, text mining | PubMed |
| Mechanisms Behind the Pharmacological Application of Biochanin-A: A review. | F1000Res | 2023 | 38106650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5607/papers?page=3